Changes of the inflammatory cytokines TNF-α and IL-6 can induce enhanced osteoclast function through the OPG/RANK/RANKL signaling pathway and may be critical for changes in bone microstructure and BMD during the “second hit” phase of NAFLD (at 24 weeks). This evidence concerns the gene TNF and metabolic dysfunction-associated steatotic liver disease.